Back to top
more

ADMA Biologics (ADMA)

(Delayed Data from NSDQ)

$8.75 USD

8.75
5,934,317

+0.03 (0.34%)

Updated Jun 26, 2026 04:00 PM ET

After-Market: $8.73 -0.02 (-0.23%) 7:58 PM ET

Zacks Rank:
Message not found:16923

5-Strong Sell of 5         5

Style Scores:
Message not found:17303

D Value A Growth C Momentum B VGM

Industry Rank:
Message not found:17304

Bottom 37% (154 out of 245)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Fundamental Charts

Research for ADMA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

About Cash from Financing (TTM)

The company's trailing twelve month (TTM) Cash from Financing is the sum of cash raised to purchase capital, repay investors, such as issuing cash dividends, adding or changing loans or issuing more stock. Cash from financing shows investors the company's financial strength. A positive cash from financing value means money is flowing into the company increasing the company's assets. A Negative cash from financing value can mean the company is servicing debt, but can also mean the company is retiring debt or making dividend payments and stock repurchases.

ADMA 8.75 +0.03(0.34%)

Will ADMA be a Portfolio Killer in June?

Zacks Investment Research is releasing its prediction for ADMA based on the 1-3 month trading system that more than doubles the S&P 500.

Click here - the ADMA analysis is free »

Zacks News for ADMA

Other News for ADMA